News

Just a summary of all the news articles that we could source from different places. A good way to make an investment decision is also to look at how actively the company is engaging with news sources to keep them in the news. In this day and age its critical to have a media presence.

Please consider a small donation if you think this website provides you with relevant information  

   
Date Title Source
2024-03-05 11:54:3 am Dyne: H2 2024 Muscle Disease Data Could Boost Value SeekingAlpha
2024-03-04 1:2:26 pm Top 2% Biotech Avidity Tumbles Despite 'Positive' Results In Treating Muscular Dystrophy Investor's Business Daily
2024-03-04 4:0:0 am Avidity Biosciences Announces Positive AOC 1001 Long-term Data Showing Reversal of Disease Progression in People Living with Myotonic Dystrophy Type 1 Across Multiple Endpoints; Same Key Endpoints Agreed for Phase 3 HARBOR™ Trial PR Newswire
2024-03-01 3:43:59 am Avidity Biosciences Full Year 2023 Earnings: Misses Expectations Simply Wall St.
2024-02-29 9:0:0 am Avidity Biosciences Honors Rare Disease Day® PR Newswire
2024-02-29 4:0:0 am Avidity Biosciences Announces Oversubscribed $400 Million Private Placement PR Newswire
2024-02-28 2:20:5 pm Avidity Biosciences, Inc. (RNA) Reports Q4 Loss, Misses Revenue Estimates Zacks
2024-02-28 1:40:1 pm Avidity Biosciences Inc (RNA) Reports Year-End Financials and Clinical Progress GuruFocus.com
2024-02-28 1:5:0 pm Avidity Biosciences Reports Fourth Quarter and Year-End 2023 Financial Results and Recent Highlights PR Newswire
   

Please consider a small donation if you think this website provides you with relevant information